Holen Sie sich die Stockscreener-App
0.6251
16.56%
-0.1241
Cdt Equity Inc Aktie (CDT) Neueste Nachrichten
CDT Equity Amends Sarborg Deal, Manages Convertible Financing - TipRanks
CDT Equity Amends $8 Million Sarborg Investment and Adds $542K Convertible Note, Later Repaid - TradingView
CDT Equity Inc. announced that it has received $1.46 million in funding from J.J. Astor & Co. - marketscreener.com
Corvus Capital's Activist Stake in CDT Equity (NASDAQ: CDT) Reaches 43.7% - Kalkine Media
Corvus Capital Converts CDT Equity (NASDAQ: CDT) Warrants into 5.44 Million Common Shares, Holding 43.7% Stake - Kalkine Media
Cdt equity CEO Andrew Regan’s entity acquires shares, disposes of 290 - Investing.com
Nearly 10% of CDT Equity Inc. (CDT) is reported in one shareholder group’s hands - Stock Titan
[Form 4] CDT Equity Inc. Insider Trading Activity - Stock Titan
[SCHEDULE 13D/A] CDT Equity Inc. Amended Major Shareholder Report - Stock Titan
CDT Equity Share Issuance Boosts Nasdaq Compliance Status - The Globe and Mail
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings - Benzinga
CDT Equity (NASDAQ: CDT) Achieves $23 Million Market Cap Following Full Warrant Conversion - Kalkine Media
CDT Equity Names James Bligh CEO Amid Leadership Shift - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
CDT Equity Inc. Reports 13.7 Million Shares Outstanding and Nasdaq Compliance - Quiver Quantitative
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies - WBOC TV
CDT Equity (CDT) Shares Fall 21% After Hours: Here's What Happened - Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
James Bligh Appointed CEO of CDT Equity (NASDAQ: CDT) Starting August 31 with $600,000 Salary - Kalkine Media
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth - The Manila Times
CDT Equity appoints James Bligh as CEO; Andrew Regan resigns - TradingView
CDT Equity names CEO, gets reverse split approval - Stock Titan
CDT Equity Inc. Announces Appointment of James Bligh to Chief Executive Officer - marketscreener.com
CDT Validates Enhanced Solid-Form Properties within Its IP Portfolio - marketscreener.com
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio - The Manila Times
CDT Equity Inc. Announces New Patent-Protected Solid Forms and AI-Identified Uses for Existing Drug Compounds - Quiver Quantitative
CDT's new drug-compound forms show improved stability and solubility - Stock Titan
CDT (CDT) Results Review: The Company Publishes Its Latest Results on the Day; Stock Move: The Stock Ends Down 18.32% in the Available RecordEarnings Beat Streak - dars.gov.et
Pep?d Inc. announced that it has received funding from CDT Equity Inc. - marketscreener.com
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market - The Manila Times
The global peptide therapeutics market is projected to reach $294.6B by 2033; CDT invests in Pep'd - Stock Titan
Enterprise value to revenue forward of CDT Equity Inc. – NASDAQ:CDTTW - TradingView
Passive 2.97% stake by investor group in CDT Equity (CDT) - Stock Titan
New 5.3% passive stake surfaces in CDT Equity Inc. (CDT) - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CDT Equity (CDT) Sarborg losses, $65M patents and going‑concern doubts - Stock Titan
CDT | CDT Equity Inc. Common Executive Compensation - Quiver Quantitative
CDT Equity Inc. Q2 2026: Net loss $(4.64M), EPS $(8.71) — 10-Q Summary - TradingView
CDT Equity Inc. (CDT) flags going concern risk despite Sarborg investment gain - Stock Titan
CDT Equity Inc. Warrant (CDTTW) Holds Steady at $0.01 Amidst Quiet TradingSymmetrical Triangle - dars.gov.et
CDT Equity Inc. SEC Filing (Aug 11, 2026) - Stock Titan
CDT Equity Expands Convertible Note and Equity Financing - The Globe and Mail
CDT Equity Inc. (Nasdaq: CDT) lifts note to $2,536,650, adds warrants - Stock Titan
CDT Equity Inc. Revenue Breakdown – BOATS:CDTTW - TradingView
CDT Equity to Boost Stake in Sarborg - marketscreener.com
Press Release: CDT Increases Stake in Sarborg Following Its Quantum Computing and Intellectual Property Expansion - 富途牛牛
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion - The Manila Times
CDT Equity Inc. agreed to acquire 22.70% stake in Sarborg Limited. - marketscreener.com
CDT Equity Expands Stake in Sarborg Via Warrants - The Globe and Mail
CDT Equity Inc. Revenue Breakdown – NASDAQ:CDT - TradingView
Form PRE 14A CDT Equity Inc For: 31 July By Investing.com - Investing.com Nigeria
CDT Equity to Acquire 4.76% of Sarborg; Issues Pre-Funded Warrants for 12.13M Shares - TradingView
CDT Equityto Buy 4.76% of SarborgSEC Fi - Moomoo
CDTTW Holds at $0.01 as Small Gain Suggests Tentative StabilizationDealer Gamma - Vinanet
CDT Equity (NASDAQ: CDT) pays consultant with 32,110 shares - Stock Titan
CDT Equity Inc. Revenue Breakdown – NASDAQ:CDTTW - TradingView
CDT|Conduit Pharmaceuticals Inc|Price:3.060|Chg%:-0.210 - TradingKey
Conduit Pharmaceuticals Inc (CDT) Income Statement - TradingKey
Ulrik K Olsen Net Worth (2026) - GuruFocus
CDT Equity Inc. Revenue Breakdown – FWB:ZK70 - TradingView
CDT Equity Company Profile & Introduction - Moomoo
CDT Equity Inc. (CDT) Stock Price, News, Quote & History - Yahoo! Finance Canada
CDT Equity notes Sarborg patent filing on sugarcane interventions - Investing.com UK
CDT Equity notes Sarborg patent filing on sugarcane interventions By Investing.com - Investing.com Nigeria
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane - The Manila Times
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):